Literature DB >> 2807164

Uptake of bile acids by perfused rat liver: evidence of a structure-activity relationship.

R Aldini1, A Roda, P Simoni, P Lenzi, E Roda.   

Abstract

The hepatic extraction of unconjugated and taurine-conjugated bile acids, provided with different hydrophilicity values, has been measured in the perfused rat liver, in order to evaluate the role of the bile acid structure and bile acid hydrophilicity on their uptake by the liver. Ursocholic, cholic, ursodeoxycholic and chenodeoxycholic acids, free and taurine-conjugated, were injected into the portal vein in dose response studies, using a nonrecirculating perfusion system. For all of the bile acids, the uptake process showed saturation. In addition, a nonsaturable component was apparent in bile acids provided with the lowest hydrophilicity values, as expressed by the lowest values of the water to octanol partition coefficient. The maximum uptake velocity increased with increasing values of the partition coefficient, which in turn were associated with 7-OH alpha to beta epimerization, the presence of 12-OH in alpha position and taurine conjugation. The ratio of maximum uptake velocity to Km (Km being the half-saturation constant) appeared to be markedly increased by taurine conjugation and by 7-OH alpha to beta epimerization, whereas it was reduced by the presence of 12-OH in alpha position.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807164     DOI: 10.1002/hep.1840100515

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of therapeutic bile acids.

Authors:  A Crosignani; K D Setchell; P Invernizzi; A Larghi; C M Rodrigues; M Podda
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

3.  Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study.

Authors:  A Crosignani; P M Battezzati; K D Setchell; P Invernizzi; G Covini; M Zuin; M Podda
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

4.  Uptake and killing of Leptospira interrogans and Borrelia burgdorferi, spirochetes pathogenic to humans, by reticuloendothelial cells in perfused rat liver.

Authors:  A Marangoni; R Aldini; V Sambri; M Montagnani; G Ballardini; E Storni; R Cevenini
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

5.  Improved intestinal absorption of an enteric-coated sodium ursodeoxycholate formulation.

Authors:  A Roda; E Roda; E Marchi; P Simoni; C Cerrè; A Pistillo; C Polimeni
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

6.  Uptake and killing of Lyme disease and relapsing fever borreliae in the perfused rat liver and by isolated Kupffer cells.

Authors:  V Sambri; R Aldini; F Massaria; M Montagnani; S Casanova; R Cevenini
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.